News

Pharmaceutical pollution in waterways is changing animal behavior. Exposure to an antianxiety drug is affecting migrating Atlantic salmon, according to a new study.
Biogen licensed rights to InnoCare's drug in a deal whose total value could ... Antibodies like Ocrevus also struggle to penetrate the CNS and hit MS at the site of the problem.
Mirati also says its drug penetrates the central nervous system more readily, making it a better option for patients whose disease has metastasised to the brain. Meanwhile, 43% of patients treated ...
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...
"FDA approves Neurelis’ nasal spray for seizures" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has b ...
The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...
New research reveals that the enzyme HDAC5 plays a critical role in suppressing a gene (Scn4b) that regulates brain activity associated with drug-related memories, which are central to relapse in ...
The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...
Research on the biological basis of addiction has found that the critical epigenetic enzyme histone deacetylase 5 (HDAC5) limits the expression of the gene Scn4b, regulating neuronal activity and ...
A new, neuroplasticity-promoting drug closely related to LSD harnesses the psychedelic’s therapeutic power with reduced ...
OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...